COMMUNIQUÉS West-GlobeNewswire

Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
12/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat [...]
HCi Viocare Rebrands Itself and Becomes Rafina Innovations Inc.
12/07/2018
Glasgow, Scotland, July 12, 2018 (GLOBE NEWSWIRE) -- HCi Viocare (OTCQB:VICA) , is pleased to announce that, further to our Current Report on Form 8-K filed June 15, 2018, HCi Viocare has completed a name change [...]
Managers' transactions
12/07/2018
Company Announcement No. 12/2018 12 July 2018 Attachment No 12 2018 US_Managers transactions
Zynerba Pharmaceuticals Announces New FAB-C Phase 2 Open-Label Data in Patients with Fragile X Syndrome
12/07/2018
- Significant Improvements in Behavioral Symptoms Observed in Patients and Sustained through 38 Weeks of Treatment with ZYN002 - - Presentation Today at the 16 th NFXF International Fragile X Conference - DEVON, Pa., [...]
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California for Stroke IP; Second Pre-Clinical Collaboration Initiated to Test the Efficacy of AST-OPC1 for the Treatment of Stroke
12/07/2018
AST-OPC1 has Demonstrated Positive Safety Profile and Promising Signs of Efficacy in a Phase 1/2a Trial for Severe Spinal Cord Injury FREMONT, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. ( [...]
Xenon Pharmaceuticals Announces At-The-Market Equity Offering
12/07/2018
BURNABY, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, announced today that it has entered into an at-the-market equity [...]
Allergy Therapeutics PLC: Trading Update
12/07/2018
Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Trading update Group’s market share continues to grow 12 July 2018 Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology [...]
ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July
12/07/2018
LEIDEN, the Netherlands, July 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]
Microbix to Present at Okanagan Capital Conference
12/07/2018
Conference Introduces Growth Companies to Investors, July 12-14, 2018 TORONTO, July 12, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX) (Microbix®), an innovator of biological products and technologies, [...]
Unum Therapeutics to Present Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the American Society of Hematology (ASH) Summit on Emerging Immunotherapies for Hematological Diseases
12/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]
InMode Introduces Triton: The World’s First and Only Simultaneous Multi-Wavelength Hair Removal
12/07/2018
NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- InMode Ltd., a manufacturer and distributor of medical-aesthetic technology to doctors around the world, is pleased to announce the launch and FDA clearance of the Triton hair [...]
Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
12/07/2018
Primary Endpoint Achieved - Statistically Significant Convulsive Seizure Reduction for ZX008 versus Placebo for Adjunctive Treatment of Seizures ZX008 Also Demonstrated Statistical Significance in All Key Secondary [...]
Auxly Announces Director Resignation
12/07/2018
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") has announced today that following his appointment as Chief Executive Officer of a [...]
ViaDerma Provides an Update to Shareholders via a Letter from the CEO
12/07/2018
The Company is also in early stage discussions to sell its product on TV LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has posted a letter from [...]
Shire plc : Rule 2.9 Announcement
12/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 July 2018 Shire [...]
Saniona receives milestone payment from Boehringer Ingelheim
12/07/2018
PRESS RELEASE July 12, 2018 Saniona, a leading biotech company within ion-channel research, today announced that Boehringer Ingelheim has selected the first candidate for pre-clinical and clinical development under [...]
Genmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer Immunotherapies
12/07/2018
Company Announcement Genmab gains exclusive access to multiple novel proprietary tumor targets identified by Immatics Biotechnologies’ XPRESIDENT ® technology Creation of novel immuno-oncology drugs combining Genmab and [...]
Van Leeuwenhoeck Issues Equity Research Note Highlighting Addex Investment Opportunity
12/07/2018
Geneva, Switzerland, 12 July 2018 – Addex Therapeutics (SIX: ADXN) announced today that the independent life science research company Van Leeuwenhoeck has issued an equity research note highlighting the Addex investment [...]
HEXO Announces Stock Option Grants to Directors, Officers and Employees
12/07/2018
GATINEAU, Quebec, July 11, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation ("HEXO" or the "Company") (TSX:HEXO) announces that it has made a grant of stock options under its stock option plan to certain of its [...]

Pages